MUC1, remodeled to express α-gal epitopes immune-based therapy can elicit both significant prolonged survival and effective antibody production against multiple tumor-associated antigens.
MUC1, remodeled to express α-gal epitopes immune-based therapy can elicit both significant prolonged survival and effective antibody production against multiple tumor-associated antigens.
复制标题
MUC1 被重构以表达 α-gal 表位，基于免疫的治疗可以显着延长生存期，并有效产生针对多种肿瘤相关抗原的抗体。
DOI：
--
复制
发表时间：
2010
期刊：
影响因子：
--
通讯作者：
Doki Y
中科院分区：
文献类型：
--
作者：
Tanemura M;Deguchi T;Miyoshi E;Nagano H;Ohmura Y;Machida T;Wada H;Kobayashi S;Marubash S;Eguchi H;Takeda Y;Ito T;Mori M;Doki Y
